Form 4: Autonomix Medical Director Lori Bisson Acquires Options
SEC Form 4 Filing
Director Lori Bisson acquired options to purchase 377,221 shares of Autonomix Medical stock on June 21, 2024.
Summary
- Lori Bisson, a director of Autonomix Medical, acquired options to purchase 377,221 shares of common stock on June 21, 2024.
- The options have an exercise price of $1.328.
- The options vest in four equal annual installments starting on June 21, 2025, contingent upon Bisson's continued service to the company.
- Following the transaction, Bisson directly owns 1,335,821 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of option grants to a director. It suggests confidence but doesn't provide concrete financial information.
Positives
- The acquisition of options by a director signals confidence in the company's future prospects.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates changes in beneficial ownership by a company insider.
Stakeholder Impact
- The acquisition of options by a director could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of the options transaction. |
| 06/21/2025 | First vesting date of the options. |
| 06/21/2034 | Expiration date of the options. |
| 06/24/2024 | Date of the Form 4 filing. |
Keywords
Autonomix Medical, AMIX, Lori Bisson, Director, Options, Form 4, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.